froggmister
10 minutes ago
Of course the JAMA article isn't sufficient for approval. To borrow a phrase from LL, it's necessary but not sufficient.
Nevertheless, please explain how MHRA will reject DCVax-L considering:
Nov 2022: JAMA confirming efficacy, and 94 neuro-oncologists disagree wit